Darwin Global Management’s Acceleron Pharma XLRN Stock Holding History

Darwin Global Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,000,000	Closed	-$344M	–	17
2021 Q3	$344M	Buy	2,000,000 +239,654	+14%	+$31.3M	63.36%	1
2021 Q2	$221M	Buy	1,760,346 +255,334	+17%	+$32.2M	35.63%	2
2021 Q1	$204M	Buy	1,505,012 +566,522	+60%	+$73.2M	39.97%	1
2020 Q4	$120M	Buy	+938,490	New	+$110M	33.5%	1

Darwin Global Management's XLRN Position: Q4 2021 in Review

Darwin Global Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 2,000,000 shares — an estimated $344M sold.

Darwin Global Management first reported a position in XLRN in Q4 2020 and held it in 4 quarters. The position peaked at $344M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Darwin Global Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Darwin Global Management sold 2,000,000 Acceleron Pharma shares in Q4 2021, an estimated $344M.
Darwin Global Management first reported a position in Acceleron Pharma in Q4 2020 and held it in 4 quarters.
Darwin Global Management's Acceleron Pharma position peaked at $344M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Darwin Global Management's 13F filing for Q4 2021, filed 14 Feb 2022.